30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Kaplan Matthew L.

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 56% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Kaplan Matthew L.'s trades of Nuvectis Pharma Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-06 2025-11-05
B Purchase
3,587 +18.7%
12.10
US$2,093,403 		3,587 +18.7% 12.10 US$2,093,403
2022-05-16 2022-05-12
B Purchase
76,935 +22.9%
282.97
US$505,254 		76,935 +22.9% 282.97 US$505,254
2022-05-16 2022-05-12
B Purchase
68,590 -42.2%
36.23
US$1,640,161 		68,590 -42.2% 36.23 US$1,640,161